Sep 4, 2025 · 55m · sourcery
Meme Lord CEO Raises $22.5M Series A for Hello Patient · Sourcery with Molly O'Shea
0:00 / 0:00
▶ Watch on YouTube →
gold bands on the timeline = statements, start to end. Hover to read, click to jump. CC turns on captions
In this episode of Sourcery, host Molly O'Shea interviews Alex Cohen, co-founder and CEO of Hello Patient, about raising a $22.5M Series A for healthcare AI and leveraging a viral online persona. Cohen discusses building conversational AI for medical practices, founder branding, and personal biohacking routines.
How this conversation actually went
Every chapter scored 0–10 on four independent dynamics. Hover any point for the reasoning behind the score. Molly holds 22.4% of the talking time here. How this is scored →
Molly as informed peer 2.4 Guest teaching 3.0 Guest disagreement 0.9 Molly pushing back 1.0
speaking balance: gold is Molly, purple is the guest (3 minute bins)
Sharpest disagreement ▶ 51:27 Pushing back against moral stigma around GLP-1 weight loss medications
Alex forcefully rejects the public criticism that using GLP-1 medications is 'cheating,' arguing that it is fundamentally no different than an athlete taking creatine.
Hardest push from Molly ▶ 4:29 Pressing Alex on skipping designer glasses after raising venture fundingMolly playfully challenges Alex's claim of frugality, asking what the point of raising substantial venture capital is if he won't spend money on custom designer glasses for the launch parody.
Biggest teaching moment ▶ 49:02 Explaining the mechanism and FDA background of TessamorellinAlex educates Molly on Tessamorellin, detailing its FDA-approved origins for reducing visceral fat in HIV patients and how it is now utilized within longevity medicine.
Molly holds their own ▶ 51:42 Molly articulating women's hormonal struggles and rapid responses to therapyMolly demonstrates deep personal and domain familiarity with female endocrine hurdles, explaining how targeted hormone interventions resolve years of stalled gym progress.
the scores for every segment, with the reasoning behind each
| Chapter | Topic | Molly as informed peer | Guest teaching | Guest disagreement | Molly pushing back | Why |
|---|---|---|---|---|---|---|
| Title Card: Sourcery Presented by Brex | 1 | 1 | 0 | 1 | The conversation opens with lighthearted banter deconstructing Alex's viral launch video parodying Sam Altman and Johnny Ive. Molly keeps the energy playful while Alex explains his wardrobe choices and video production details. | |
| Deconstructing Alex's Viral Firing Tweets | 2 | 1 | 1 | 1 | Molly reviews Alex's long-running satirical gag of tweeting about being fired from major tech companies. The exchange remains friendly as Alex provides background on the viral tweet format that originated during Elon Musk's Twitter takeover. | |
| Founding Hello Patient & Raising a $22.5M Series A | 2 | 3 | 0 | 0 | Alex discusses his departure from Carbon Health following a strategic pivot and how he validated voice AI before raising a $22.5M Series A. Molly guides the conversation with standard venture and fundraising questions. | |
| Turning Social Media Shitposting into a Business Advantage | 2 | 3 | 1 | 1 | Alex details how social media shitposting translates into executive networking access, storytelling ability, and inbound business leads. Molly probes how enterprise healthcare clients and lead investors react to his public online persona. | |
| Sponsor Break: Brex Financial Stack | 3 | 4 | 1 | 1 | After an opening Brex ad read, Alex dives deep into Hello Patient's technical architecture, specialty verticals, and complex triaging workflows. Molly asks structured questions covering market adoption, sales proofs of concept, and HIPAA data compliance. | |
| Sponsor Break: Turing Intelligence | 3 | 4 | 2 | 2 | Following a Turing ad read, Alex explains why administrative AI is currently more viable than clinical diagnosis and offers a grounded 5 to 7 year estimate for AGI based on agent unreliability. Molly presses him on specific AI timelines and competition against entrenched EHR incumbents. | |
| Biohacking, Hormones, and Peptides Deep Dive | 4 | 5 | 1 | 1 | Alex delivers an extensive breakdown of biohacking protocols, TRT trade-offs, peptide cycling, and tirzepatide microdosing. Molly actively engages in the discussion by sharing observations on women's hormonal challenges and systemic issues within the US food supply. |
Statements from this episode (11)
Cohen: Hello Patient couples every funding raise with a parody video
“Every time we do a raise, it's like in conjunction with a parody video.”
Cohen: Hello Patient raised a $22.5M Series A
“We've raised a 22 and a half million dollar Series A.”
Hello Patient seed investors exercised full pro-rata in its Series A
“All of our original investors did. So the seed round was ABC, Bling Capital, Max Ventures. The extension was, or like the top up, whatever you want to call it, was also all three of them. Like they all kept wanting to do more. And then this round, like scale w…”
Cohen: Most Hello Patient traffic is inbound since launch video
“I mean, like, literally, since our launch video, like, majority of our traffic has come inbound now, like, to our website and, like, even healthcare providers reaching out.”
Cohen: Hello Patient focuses exclusively on patient-facing AI communication
“We build conversational AI agents or, you know, whatever you want to call them, but conversational AI for healthcare practices that we exclusively deal with patient facing communication.”
Cohen: Anthropic's Claude is too slow for real-time phone calls
“We've tried Gemini, Claude and Anthropic are a little bit too slow for a phone call, unfortunately.”
Cohen: Hello Patient has a 2-3 year head start over EHR incumbents
“I think we still have a two to three year head start to like really get good and ingrain and go sell and be like best in class at patient engagement because they're really that last 10% really does matter.”
Cohen: Incumbent EHR giants will not be unseated in 3-5 years
“Like, the EHRs aren't going anywhere. Epic has a complete, basically, like, oligopoly over the entire space. ModMen and Athena are massive companies. Like, I don't think anyone is unseating them in the next three to five years”
Cohen: Every man over 30 should get hormone levels tested
“TRT, which is not a peptide, but again, I think every guy like over 30 should get tested for their hormone levels and then decide if they want to do it.”
Cohen: Taking GLP-1s for weight loss is no different than taking creatine
“I don't think people should be judged for taking it either. I think there's a lot of like stigma around it and people are like, you cheated at losing weight. And it's like, I don't see how it's different than taking creatine to put on, you know, water weight a…”
Cohen: Jony Ive and Sam Altman will announce AI glasses
“I think it's gonna be a pair of glasses. I think, like, that's the only form function that my, again, like, Johnny genuinely, like, understands the future, I think, of, god, I'm, like, going into acting mode, but, like, he genuinely understands the like, hardw…”